세계의 성인 척추 변형 시장 : 인사이트, 경쟁 환경, 시장 예측(-2032년)

Adult Spinal Deformity - Market Insights, Competitive Landscape, and Market Forecast - 2032

US $ 3,750 ￦ 5,181,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,688 ￦ 6,477,000

PDF (2-3 User License)

PDF 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,625 ￦ 7,772,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,362,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

성인 척추 변형(ASD) 시장 규모는 2025년부터 2032년까지 예측 기간 동안 5.57%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다. 성인 척추 변형에 대한 수요는 주로 전 세계적으로 척수 손상 및 장애의 유병률이 증가함에 따라 증가하고 있습니다. 또한, 비만과 좌식 생활 습관 증가, 수술 기술 및 기술 발전 증가는 2025년부터 2032년까지 예측 기간 동안 성인 척추 변형 시장의 성장에 기여하는 주요 요인 중 일부입니다.

세계보건기구(WHO)가 2025년에 발표한 자료에 따르면, 2021년에 전 세계적으로 약 1,510만 명이 척수손상을 앓고 있는 것으로 나타났습니다. 또한, 세계보건기구(WHO) 2021년 발표 자료에 따르면 매년 전 세계적으로 25만 명에서 50만 명이 척수손상(SCI)을 입고 있으며, 척수손상의 대부분은 교통사고, 낙상, 폭력으로 인한 것입니다. 척수 손상과 척수 장애 증가는 이러한 질병과 관련된 합병증과 변형을 경험하는 환자 수를 직접적으로 증가시킵니다. 이러한 환자 수 증가는 성인 척추 변형과 관련된 치료 및 외과적 개입에 대한 수요 증가로 이어집니다. 따라서 전 세계적으로 척수 손상 및 척수 장애의 유병률이 증가함에 따라 예측 기간 동안 성인 척추 변형 시장은 확대될 것으로 예상됩니다.

성인 척추 변형 시장의 긍정적인 성장에 영향을 미치는 또 다른 요인은 비만과 좌식 생활습관 증가입니다. 세계보건기구(WHO)가 2022년에 제공한 데이터에 따르면, 2022년에는 전 세계 인구의 39%를 차지하는 약 19억 명이 과체중 범주에 속할 것으로 추정됩니다. 이 중 6억 5,000만 명 이상이 비만과 공존하며 세계 인구의 약 13%를 차지합니다. 과체중과 비만은 척추에 추가적인 부담을 주어 다양한 척추 질환과 변형을 유발합니다. 과체중은 추간판의 퇴행을 가속화하고 정렬 불일치를 유발하여 추간판탈출증, 척추관협착증, 퇴행성 추간판증과 같은 질환의 발병에 일조합니다. 이러한 비만 인구 증가로 인한 척추 장애 증가는 ASD에 대한 치료 수요의 원동력이 됩니다. 따라서 성인 척추변형 시장은 향후 확대될 것으로 예상됩니다.

세계의 성인 척추 변형 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 용도별, 최종사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 성인 척추 변형 시장 보고서 서론

제2장 성인 척추 변형 시장 주요 요약

제3장 경쟁 구도

제4장 규제 분석

• 미국
• 유럽
• 일본
• 중국

제5장 성인 척추 변형 시장의 주요 요인 분석

• 성인 척추 변형 시장 성장 촉진요인
• 성인 척추 변형 시장 성장 억제요인과 과제
• 성인 척추 변형시 장소 기회

제6장 성인 척추 변형 시장 : Porter의 Five Forces 분석

제7장 성인 척추 변형 시장 평가

• 제품 유형별
  • 경추 고정 기기
  • 추체간 고정 기기
  • 흉요추 기기
  • 기타
• 용도별
  • 척추 후만증
  • 척추 전만증
  • 척추 측만증
• 최종사용자별
  • 병원 및 진료소
  • 외래수술센터(ASC)
• 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제8장 성인 척추 변형 시장 기업과 제품 개요

• Stryker
• B. Braun SE
• Zimmer Biomet
• Medtronic
• Johnson & Johnson Services, Inc.
• Globus Medical
• NovApproach Spine
• NuVasive
• Orthofix Medical Inc.
• RTI Surgical
• Astura Medical
• Aurora Spine Corporation
• Life Spine, Inc.
• Spineway France
• Spine Wave, Inc.
• Precision Spine
• Implanet
• Tasarimmed Tibbi Mamuller San. Tic A.S.
• Ortho-technical laboratory of the spine
• ATEC Spine, Inc.

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항과 문의

LSH

영문 목차

영문목차

Adult Spinal Deformity Market by Product Type (Cervical Fixation Devices, Interbody Fusion Devices, Thoracolumbar Devices, and Others), Application (Kyphosis, Lordosis, Scoliosis, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of spinal cord injuries and disorders and increasing incidence of obesity and sedentary lifestyle around the globe.

The Adult Spinal Deformity (ASD) market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032. The demand for adult spinal deformity is primarily being boosted by the increasing prevalence of spinal cord injuries and disorders around the globe. Additionally, increasing incidences of obesity and sedentary lifestyles and growing advancement in surgical techniques and technologies are some of the key factors, which are contributing to the growth of the adult spinal deformity market during the forecast period from 2025 to 2032.

ADULT SPINAL DEFORMITY MARKET DYNAMICS:

According, to the data provided by the World Health Organization (WHO) 2025, in 2021 globally approximately 15.1 million people were living with spinal cord injury. Additionally, as per the data published by the World Health Organization 2021, every year between 250,000 and 500,000 people suffer a spinal cord injury (SCI) around the world and the majority of spinal cord injuries are due to road traffic crashes, falls, or violence. The rise in spinal cord injuries and disorders directly increases the number of individuals experiencing complications and deformities related to these conditions. This larger patient population will lead to a higher demand for treatments and surgical interventions associated with adult spinal deformities. Thus, the increasing prevalence of spinal cord injuries and disorders across the globe will boost the market for adult spinal deformities during the forecast period.

Another factor influencing the positive growth of the adult spinal deformity market is the increasing obesity and sedentary lifestyle. As per the data provided by the World Health Organization 2022, it was estimated that approximately 1.9 billion people, which accounted for 39% of the world's population were within the overweight category in 2022, globally. Of these, more than 650 million people were living with obesity, which accounted for approximately 13% of the global population. Excess body weight or obesity places additional stress on the spine, leading to various spinal disorders or deformities. Excess body weight can accelerate the degeneration of intervertebral discs, cause misalignment, and contribute to the development of conditions such as herniated discs, spinal stenosis, and degenerative disc disease. This increase in spinal disorders owing to an increase in the obesity population will drive the demand for treatments for ASD. Thus, boosting the market for adult spinal deformities in the coming future.

However, the high cost associated with spinal surgeries, and risk of complications, and the long recovery period associated with spinal surgeries are some of the key constraints that may limit the growth of the adult spinal deformity market.

ADULT SPINAL DEFORMITY MARKET SEGMENT ANALYSIS:

Adult Spinal Deformity Market by Product Type (Cervical Fixation Devices, Interbody Fusion Devices, Thoracolumbar Devices, and Others), Application (Kyphosis, Lordosis, Scoliosis, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the adult spinal deformity market, the interbody fusion devices category is estimated to amass a significant revenue share in the adult spinal deformity market in 2024. This can be attributed to the various applications and advantages provided by interbody fusion devices. These devices are highly effective in treating a wide range of spinal disorders, including degenerative disc disease, spondylolisthesis, spinal stenosis, and deformities like scoliosis and kyphosis. They provide stability to the spine by fusing two or more vertebrae, alleviating pain, and restoring proper alignment. Additionally, significant advancements in interbody fusion technology have made these devices more effective and safer. Innovations include minimally invasive surgical techniques, biological materials for enhanced bone growth, and the development of more durable and adaptable implants. These advancements improve patient outcomes and expand the use of interbody fusion devices. Further, interbody fusion devices can be used in various regions of the spine (cervical, thoracic, and lumbar), making them versatile and applicable to a broad spectrum of spinal conditions. This versatility contributes to their high demand and market share.

Moreover, various product launches and product approvals in this category will also help to boost the market share of the category. For instance, in October 2023, NovApproach Spine, developer of the patented OneLIF(TM) interbody spinal fusion system which supports a multitude of surgical approaches, announced the market launch of the OneLIF(TM) interbody spinal fusion system during the North American Spine Society's Annual Meeting.

Therefore, owing to the above-mentioned factors, the interbody fusion devices category is expected to register significant growth, thereby driving the growth of the overall adult spinal deformity market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL ADULT SPINAL DEFORMITY MARKET:

North America is expected to account for the highest proportion of the adult spinal deformity market in 2024, out of all regions. This is due to the growing prevalence of spinal deformities. Additionally, the increasing prevalence of obesity and a sedentary lifestyle, the presence of robust research and development initiatives, and the presence of an aging population are some of the key factors driving the growth of the adult spinal deformity market in North America.

As per the data provided by the United Spinal Association in the year 2022, around 17,700 Americans suffered spinal cord injuries annually, with 78% of cases occurring in men at an average age of 43. Vehicular accidents account for 39.3% of injuries, followed by falls at 31.8%, violence at 13.2%, sports at 8%, and medical/surgery at 4.3%. Thus, the rising incidence of spinal injuries leading to deformities will create a need for the treatment and management of such disorders resulting in the increased market of adult spinal deformity in the United States, which will in return propel the market for adult spinal deformity in North America.

According to the data provided by the Centers for Disease Control and Prevention 2023, the older adult population is growing substantially, and by 2060 almost a quarter of the U.S. population will be aged 65 years or older. As age increases human body is prone to various degenerative spine conditions leading to deformities in the spinal area. Thus, with the increase in the older population, the market for adult spinal deformities will increase, during the forecast period.

Moreover, various product approvals in the region will also help to boost the market share in North America. For instance in May 2023, Astura Medical announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Sirion X Expandable Lateral Lumbar Interbody Fusion (LLIF) System.

Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for adult spinal deformity in the North America region during the forecast period.

ADULT SPINAL DEFORMITY MARKET KEY PLAYERS:

Some of the key market players operating in the adult spinal deformity market include Stryker, B. Braun SE, Zimmer Biomet, Medtronic, Johnson & Johnson Services, Inc., Globus Medical, NovApproach Spine, SeaSpine, RTI Surgical, Astura Medical, Aurora Spine Corporation, Life Spine, Inc., Spineway France, Precision Spine, Spine Wave, Inc., Implanet, Tasarimmed TIbbi Mamuller San. Tic A.S., and Ortho-technical laboratory of the spine.

RECENT DEVELOPMENTAL ACTIVITIES IN THE ADULT SPINAL DEFORMITY MARKET:

• In July 2022, the US Food and Drug Administration (FDA) granted 510K clearance for Aurora Spine's DEXA SOLO-L anterior lumbar interbody fusion device (ALIF).
• In March 2021, Aurora Spine Corporation announced the launch of its propriety SiLOTM Posterior SI Joint Fusion System.

KEY TAKEAWAYS FROM THE ADULT SPINAL DEFORMITY MARKET REPORT STUDY

• Market size analysis for current adult spinal deformity market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the adult spinal deformity market.
• Various opportunities available for the other competitors in the adult spinal deformity market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current adult spinal deformity market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for adult spinal deformity market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS ADULT SPINAL DEFORMITY MARKET REPORT STUDY

• Adult spinal deformity product providers
• Research organizations and consulting companies
• Adult spinal deformity-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in the adult spinal deformity market
• Various end-users who want to know more about the adult spinal deformity market and the latest technological developments in the adult spinal deformity market.

FREQUENTLY ASKED QUESTIONS FOR THE ADULT SPINAL DEFORMITY MARKET:

1. What is meant by adult spinal deformities?

• Adult spinal deformities refer to abnormal curvatures or misalignments of the spine that develop or persist into adulthood. These deformities can result from various causes, including degenerative changes, previous spinal conditions, trauma, or congenital abnormalities.

2. What is the market for adult spinal deformities?

• The Adult Spinal Deformity (ASD) market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032.

3. What are the drivers for the global adult spinal deformity market?

• The adult spinal deformity market is primarily being boosted by the increasing prevalence of spinal cord injuries and disorders around the globe. Additionally, increasing incidence of obesity and sedentary lifestyles and growing advancement in surgical techniques and technologies are some of the key factors, which are contributing to the growth of the adult spinal deformity market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global adult spinal deformity market?

• Some of the key market players operating in the adult spinal deformity market include Stryker, B. Braun SE, Zimmer Biomet, Medtronic, Johnson & Johnson Services, Inc., Globus Medical, NovApproach Spine, SeaSpine, RTI Surgical, Astura Medical, Aurora Spine Corporation, Life Spine, Inc., Spineway France, Precision Spine, Spine Wave, Inc., Implanet, Tasarimmed TIbbi Mamuller San. Tic A.S., and Ortho-technical laboratory of the spine.

5. Which region has the highest share in the global adult spinal deformity market?

• North America is expected to dominate the overall adult spinal deformity market during the forecast period, 2025 to 2032. This is due to the growing prevalence of spinal deformities. Additionally, the increasing prevalence of obesity and sedentary lifestyle, the presence of robust research and development initiatives, and the presence of an aging population are some of the key factors driving the growth of the adult spinal deformity market in North America.

Table of Contents

1. Adult Spinal Deformity Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Adult Spinal Deformity Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Adult Spinal Deformity Market Key Factors Analysis

• 5.1. Adult Spinal Deformity Market Drivers
  • 5.1.1. Rising prevalence of spinal disorders
  • 5.1.2. Increasing incidence of obesity and sedentary lifestyle
  • 5.1.3. Growing advancement in surgical techniques and technologies
• 5.2. Adult Spinal Deformity Market Restraints and Challenges
  • 5.2.1. High cost associated with spinal surgeries
  • 5.2.2. Risk of complications and long recovery period associated with spinal surgeries
• 5.3. Adult Spinal Deformity Market Opportunities
  • 5.3.1. Usage of robotic-assisted surgery and machine learning in reducing surgical risk

6. Adult Spinal Deformity Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Adult Spinal Deformity Market Assessment

• 7.1. By Product Type
  • 7.1.1. Cervical Fixation Devices
  • 7.1.2. Interbody Fusion Devices
  • 7.1.3. Thoracolumbar Devices
  • 7.1.4. Others
• 7.2. By Application
  • 7.2.1. Kyphosis
  • 7.2.2. Lordosis
  • 7.2.3. Scoliosis
  • 7.2.4. Others
• 7.3. By End-Users
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Adult Spinal Deformity Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Adult Spinal Deformity Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.3.3. India Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Adult spinal Deformity Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Adult Spinal Deformity Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Adult Spinal Deformity Market Size in USD million (2022-2032)

8. Adult Spinal Deformity Market Company and Product Profiles

• 8.1. Stryker
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. B. Braun SE
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Zimmer Biomet
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Medtronic
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Johnson & Johnson Services, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Globus Medical
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. NovApproach Spine
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. NuVasive
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Orthofix Medical Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. RTI Surgical
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Astura Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Aurora Spine Corporation
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Life Spine, Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Spineway France
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Spine Wave, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Precision Spine
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Implanet
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Tasarimmed Tibbi Mamuller San. Tic A.S.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Ortho-technical laboratory of the spine
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. ATEC Spine, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

관련자료